Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CBLB | Q13191 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2124456 | 0.98 | KMT2A (0.34) | KMT2AATMCBLBHTT | |
| SCHEMBL14443968 | 0.87 | GAA (0.39) | KMT2AATMCBLBHTTALDH1A1 | |
| Hydrochloric Acid SCHEMBL5332076 | 0.85 | GAA (0.38) | KMT2AATMCBLBHTTALDH1A1 | |
| SCHEMBL154890 | 0.84 | KMT2A (0.36) | KMT2AATMCBLBALDH1A1TSHR | |
| SCHEMBL19484356 | 0.84 | BBOX1 (0.37) | KMT2AATMCBLB | |
| SCHEMBL21783321 | 0.83 | CBLB (0.43) | KMT2AATMCBLBHTT | |
| Hydrochloric Acid SCHEMBL153335 | 0.83 | KMT2A (0.35) | KMT2AATMCBLBALDH1A1TSHR | |
| SCHEMBL23375507 | 0.82 | CBLB (0.42) | KMT2AATMCBLBHTT | |
| SCHEMBL18327379 | 0.82 | CBLB (0.42) | KMT2AATMCBLBHTT | |
| SCHEMBL18327380 | 0.82 | CBLB (0.42) | KMT2AATMCBLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12447133-B2 | Composition and device for preventing hypoglycemia and use thereof | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2025-10-21 | — | — | US | claimed |
| US-12447133-B2 | Composition and device for preventing hypoglycemia and use thereof | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2025-10-21 | — | — | US | disclosed |
| US-9797886-B2 | Agglutination enhancer | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20100069544-A1 | HYDROGEL CONTACT LENS COMPRISING A POLYMER COMPRISING A CARBOXY BETAINE ESTER MONOMER | PROCORNEA HOLDING B.V. | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069544-A1 | HYDROGEL CONTACT LENS COMPRISING A POLYMER COMPRISING A CARBOXY BETAINE ESTER MONOMER | CRYAA, CRYZ, CRYAB | KMT2A 2125/4885ATM 758/4885CBLB 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.